God enough if production is cheap

COVID antibodies in patients with mild symptoms fade quickly, raising concerns that their immunity from a future infection may not last very long, researchers said in the New England Journal of Medicine.
The first analysis was done on antibodies taken an average of 37 days after symptoms began, with a second after about 86 days, or less than three months.
The researchers determined that antibody levels had fallen precipitously, with a half-life of about 73 days between the two time frames.

That raises concern that immunity may not last long in people who develop a mild infection, which accounts for the majority of cases.

If some mRNA process, in or out of our body, can generate the antibodies cheaply then fine, we can use our inhaler.  It is a start and if done cheaply will drop R down sufficiently to open up more of the economy.